why choose us

First received: July 11, 2022

Clinical Trial: The Effectiveness of Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for Critically Ill Surgical Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Surgery-Complications

Study Type: OBSERVATIONAL


Official Title: The Effectiveness of the Urine Mitochondrial Deoxyribonucleic Acid and, Serum Beta 2 Microglobulin as a Biomarker of Renal Function Impairment in Critically Ill Surgical Patients

Brief Summary: 1. Research backgroundResearch hypothesis The development of acute kidney injury (AKI) can be predicted using urine mitochondrial deoxyribonucleic acid (UmtDNA), serum and urine beta-2 microglobulin (?2-MG) in critically ill surgical patientsBasis of research hypothesisi. Correlation between mitochondria and renal function (Results of previous studies)Mitochondria are involved in development and recovery of diabetic nephropathy.UmtDNA can be used as early marker to detect the development of AKI? MitochondriaAs an…

Read more